Skip to main content
. 2021 Apr 15;29(11):6297–6304. doi: 10.1007/s00520-021-06198-6

Table 2.

Demographics and general clinical data of our population and the control group derived from Bjordal et al. [15]. Data are expressed as absolute values and percentage in brackets. COPD, chronic obstructive pulmonary disease; HNC, head and neck cancer; LP, laryngectomized population; NA, not available; RT, radiotherapy

Overall population [121] Control group [360] p-value LP group [64] Other HNC [57] p-value
Median age (range) 67 (35–95) 61 (22–91) - Subgroup analysis of our population [121] 73.5 (44–95) 64 (35–87) -
Sex 0.107
Male 91 (75.2) 295 52 39
Female 30 (24.8)

(81.9)

65 (18.1)

(81.2)

12 (18.8)

(68.4)

18 (31.6)

0.103
Positive smoking history 83 (68.6) NA - 47 (73.4) 36 (63.2) 0.224
Mean pack/years 72.4 NA - 63.23 79.53 0.196
COPD/asthma 23 (19) NA - 15 (23.4) 8 (14) 0.188
Site 0.380 -

Oral cavity

Oropharynx

Larynx

Hypopharynx

Nasopharynx

34 (28.1)

12 (9.9)

63 (52)

5 (4.2)

7 (5.8)

107 (29.7)

41 (11.3)

185 (51.3)

19 (5.2)

8 (2.5)

-

-

59 (92.2)

5 (7.8)

-

34 (59.6)

12 (21)

4 (7.1)

0 (0)

7 (12.3)

History of previous RT 98 (80.9) 309 (85.8) 0.201 56 (71.8) 42 (49.1) 0.053